- call +1-201-465-4211
- email sales@mrinsights.biz
GABA (γ-aminobutyric acid) is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Scope of the Report:
Gamma-Amino Butyric acid (GABA) is an amino acid which acts as a neurotransmitter in the central nervous system. It inhibits nerve transmission in the brain, calming nervous activity. GABA plays an important role in behavior, cognition, and the body's response to stress. Lower-than-normal levels of GABA in the brain have been linked to schizophrenia, depression, anxiety, and sleep disorders.
At present, there are two ways to produce GABA: chemical synthesis method and biological fermentation method. Among them, biological fermentation method feeding on monosodium glutamate and lactobacillus, is safer and more widely used. The price of GABA produced from monosodium glutamate and lactobacillus is relatively higher. As the limitation of application fields, the market share of chemical synthesis product decreased.
The worldwide market for GABA (CAS 56-12-2) is expected to grow at a CAGR of roughly 4.6% over the next five years, will reach 46 million US$ in 2023, from 35 million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the GABA (CAS 56-12-2) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pharma Foods International
Kyowa Hakko
Sekisui Chemical
Zhejiang YiWan Biolabs
Shanghai Richen
Guangdong Luckerkong Biotech
Tianjin Shijitianlong Biotech
Ningxiang Jiayuan Biology Technology
Zhejiang Tianrui Chemical
Taizhou Xinyou Pharmaceutical & Chemical
Bloomage Freda Biopharm
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chemical Synthesis
Biological Fermentation
Market Segment by Applications, can be divided into
Pharmaceuticals & Health
Food & Beverage
Animal Feeds
Others
There are 15 Chapters to deeply display the global GABA (CAS 56-12-2) market.
Chapter 1, to describe GABA (CAS 56-12-2) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of GABA (CAS 56-12-2), with sales, revenue, and price of GABA (CAS 56-12-2), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of GABA (CAS 56-12-2), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, GABA (CAS 56-12-2) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe GABA (CAS 56-12-2) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 GABA (CAS 56-12-2) Introduction
1.2 Market Analysis by Type
1.2.1 Chemical Synthesis
1.2.2 Biological Fermentation
1.3 Market Analysis by Applications
1.3.1 Pharmaceuticals & Health
1.3.2 Food & Beverage
1.3.3 Animal Feeds
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pharma Foods International
2.1.1 Business Overview
2.1.2 GABA (CAS 56-12-2) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pharma Foods International GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Kyowa Hakko
2.2.1 Business Overview
2.2.2 GABA (CAS 56-12-2) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Kyowa Hakko GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sekisui Chemical
2.3.1 Business Overview
2.3.2 GABA (CAS 56-12-2) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sekisui Chemical GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Zhejiang YiWan Biolabs
2.4.1 Business Overview
2.4.2 GABA (CAS 56-12-2) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Shanghai Richen
2.5.1 Business Overview
2.5.2 GABA (CAS 56-12-2) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Shanghai Richen GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Guangdong Luckerkong Biotech
2.6.1 Business Overview
2.6.2 GABA (CAS 56-12-2) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Tianjin Shijitianlong Biotech
2.7.1 Business Overview
2.7.2 GABA (CAS 56-12-2) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ningxiang Jiayuan Biology Technology
2.8.1 Business Overview
2.8.2 GABA (CAS 56-12-2) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Zhejiang Tianrui Chemical
2.9.1 Business Overview
2.9.2 GABA (CAS 56-12-2) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Taizhou Xinyou Pharmaceutical & Chemical
2.10.1 Business Overview
2.10.2 GABA (CAS 56-12-2) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Bloomage Freda Biopharm
2.11.1 Business Overview
2.11.2 GABA (CAS 56-12-2) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bloomage Freda Biopharm GABA (CAS 56-12-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global GABA (CAS 56-12-2) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global GABA (CAS 56-12-2) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global GABA (CAS 56-12-2) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 GABA (CAS 56-12-2) Manufacturer Market Share in 2017
3.3.2 Top 6 GABA (CAS 56-12-2) Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global GABA (CAS 56-12-2) Market Analysis by Regions
4.1 Global GABA (CAS 56-12-2) Sales, Revenue and Market Share by Regions
4.1.1 Global GABA (CAS 56-12-2) Sales and Market Share by Regions (2013-2018)
4.1.2 Global GABA (CAS 56-12-2) Revenue and Market Share by Regions (2013-2018)
4.2 North America GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
4.3 Europe GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
4.5 South America GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
5 North America GABA (CAS 56-12-2) by Countries
5.1 North America GABA (CAS 56-12-2) Sales, Revenue and Market Share by Countries
5.1.1 North America GABA (CAS 56-12-2) Sales and Market Share by Countries (2013-2018)
5.1.2 North America GABA (CAS 56-12-2) Revenue and Market Share by Countries (2013-2018)
5.2 United States GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
5.3 Canada GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
5.4 Mexico GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
6 Europe GABA (CAS 56-12-2) by Countries
6.1 Europe GABA (CAS 56-12-2) Sales, Revenue and Market Share by Countries
6.1.1 Europe GABA (CAS 56-12-2) Sales and Market Share by Countries (2013-2018)
6.1.2 Europe GABA (CAS 56-12-2) Revenue and Market Share by Countries (2013-2018)
6.2 Germany GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
6.3 UK GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
6.4 France GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
6.5 Russia GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
6.6 Italy GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
7 Asia-Pacific GABA (CAS 56-12-2) by Countries
7.1 Asia-Pacific GABA (CAS 56-12-2) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific GABA (CAS 56-12-2) Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific GABA (CAS 56-12-2) Revenue and Market Share by Countries (2013-2018)
7.2 China GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
7.3 Japan GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
7.4 Korea GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
7.5 India GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
7.6 Southeast Asia GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
8 South America GABA (CAS 56-12-2) by Countries
8.1 South America GABA (CAS 56-12-2) Sales, Revenue and Market Share by Countries
8.1.1 South America GABA (CAS 56-12-2) Sales and Market Share by Countries (2013-2018)
8.1.2 South America GABA (CAS 56-12-2) Revenue and Market Share by Countries (2013-2018)
8.2 Brazil GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
8.3 Argentina GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
8.4 Colombia GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
9 Middle East and Africa GABA (CAS 56-12-2) by Countries
9.1 Middle East and Africa GABA (CAS 56-12-2) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa GABA (CAS 56-12-2) Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa GABA (CAS 56-12-2) Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
9.3 UAE GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
9.4 Egypt GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
9.5 Nigeria GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
9.6 South Africa GABA (CAS 56-12-2) Sales and Growth Rate (2013-2018)
10 Global GABA (CAS 56-12-2) Market Segment by Type
10.1 Global GABA (CAS 56-12-2) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global GABA (CAS 56-12-2) Sales and Market Share by Type (2013-2018)
10.1.2 Global GABA (CAS 56-12-2) Revenue and Market Share by Type (2013-2018)
10.2 Chemical Synthesis Sales Growth and Price
10.2.1 Global Chemical Synthesis Sales Growth (2013-2018)
10.2.2 Global Chemical Synthesis Price (2013-2018)
10.3 Biological Fermentation Sales Growth and Price
10.3.1 Global Biological Fermentation Sales Growth (2013-2018)
10.3.2 Global Biological Fermentation Price (2013-2018)
11 Global GABA (CAS 56-12-2) Market Segment by Application
11.1 Global GABA (CAS 56-12-2) Sales Market Share by Application (2013-2018)
11.2 Pharmaceuticals & Health Sales Growth (2013-2018)
11.3 Food & Beverage Sales Growth (2013-2018)
11.4 Animal Feeds Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 GABA (CAS 56-12-2) Market Forecast (2018-2023)
12.1 Global GABA (CAS 56-12-2) Sales, Revenue and Growth Rate (2018-2023)
12.2 GABA (CAS 56-12-2) Market Forecast by Regions (2018-2023)
12.2.1 North America GABA (CAS 56-12-2) Market Forecast (2018-2023)
12.2.2 Europe GABA (CAS 56-12-2) Market Forecast (2018-2023)
12.2.3 Asia-Pacific GABA (CAS 56-12-2) Market Forecast (2018-2023)
12.2.4 South America GABA (CAS 56-12-2) Market Forecast (2018-2023)
12.2.5 Middle East and Africa GABA (CAS 56-12-2) Market Forecast (2018-2023)
12.3 GABA (CAS 56-12-2) Market Forecast by Type (2018-2023)
12.3.1 Global GABA (CAS 56-12-2) Sales Forecast by Type (2018-2023)
12.3.2 Global GABA (CAS 56-12-2) Market Share Forecast by Type (2018-2023)
12.4 GABA (CAS 56-12-2) Market Forecast by Application (2018-2023)
12.4.1 Global GABA (CAS 56-12-2) Sales Forecast by Application (2018-2023)
12.4.2 Global GABA (CAS 56-12-2) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure GABA (CAS 56-12-2) Picture
Table Product Specifications of GABA (CAS 56-12-2)
Figure Global Sales Market Share of GABA (CAS 56-12-2) by Types in 2017
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
